• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Serological evidence of SARS-CoV-2 exposure in marine mammals in the United States between 2020 and 2025

tetano

Editor, Senior Moderator
PLoS One


. 2026 Jul 9;21(7):e0351734.
doi: 10.1371/journal.pone.0351734. eCollection 2026.
Serological evidence of SARS-CoV-2 exposure in marine mammals in the United States between 2020 and 2025

Idrissa Nonmon Sanogo[SUP] 1 [/SUP], Wendy B Puryear[SUP] 1 [/SUP], Alexa F Simulynas[SUP] 1 [/SUP], Robert DiGiovanni[SUP] 2 [/SUP], Caroline E Goertz[SUP] 3 [/SUP], Natalie Hunter[SUP] 3 [/SUP], Kathy Burek Huntington[SUP] 4 [/SUP], Natalie Rouse[SUP] 4 [/SUP], Rosemary E Seton[SUP] 5 [/SUP], Nicole E Hunter[SUP] 6 [/SUP], Kim Schulam[SUP] 7 [/SUP], Stephen J St Pierre[SUP] 7 [/SUP], Lynda Doughty[SUP] 8 [/SUP], Jay Pagel[SUP] 9 [/SUP], Allison D Tuttle[SUP] 10 [/SUP], Sarah Callan[SUP] 10 [/SUP], Marina A Piscitelli-Doshkov[SUP] 11 [/SUP], Lisa Becker[SUP] 12 [/SUP], Brian Fadely[SUP] 13 [/SUP], Sarah M Chinn[SUP] 13 [/SUP], Anthony J Orr[SUP] 13 [/SUP], Heather Ziel[SUP] 13 [/SUP], Josh London[SUP] 13 [/SUP], Jessica L Huggins[SUP] 14 [/SUP], Deborah Fauquier[SUP] 15 [/SUP], Sarah Wilkin[SUP] 15 [/SUP], Ainsley Smith[SUP] 16 [/SUP], Margot Madden[SUP] 17 [/SUP], Maxine A Montello[SUP] 18 [/SUP], Alissa C Deming[SUP] 19 [/SUP], Michelle R Rivard[SUP] 20 [/SUP], Ashley Stokes[SUP] 21 [/SUP], Lauren McDowell[SUP] 21 [/SUP], Joanna Daniel[SUP] 22 [/SUP], Dyanna Lambourn[SUP] 23 [/SUP], Suzanne Thurman[SUP] 24 [/SUP], Michelle Barbieri[SUP] 25 [/SUP], Claudia Cedillo[SUP] 25 [/SUP], Jonathan A Runstadler[SUP] 1 [/SUP]


Affiliations
Abstract

Natural infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been documented in over 60 animal species, some distantly related. Several marine mammals have been predicted as highly susceptible to SARS-CoV-2 infection based on the homology of their ACE2 receptors to those of humans. To assess potential exposure of marine mammals to SARS-CoV-2, we conducted an opportunistic survey from 2020 to 2025 and tested 1,808 swabs and 378 serum samples from 21 marine mammal species in the United States. All the swabs tested by RT-qPCR were negative, indicating the absence of active infection. A low level of SARS-CoV-2 neutralizing antibodies was detected in three pinniped species, including Phoca vitulina (harbor seal, 13.6%, 95% CI: 5.2-27.4%), Zalophus californianus (California sea lion, 7%, 95% CI: 1.9-17.0%), and Halichoerus grypus (grey seal, 3.7%, 95% CI: 0.5-12.7%). These findings represent the first serological evidence of SARS-CoV-2 exposure in marine mammals in the United States, highlighting the need for continued monitoring of these populations and further research on SARS-CoV-2 transmission dynamics in wildlife.


 
Back
Top